Cure My Disease

Don't miss your cure!

 Log in / Sign up

Cancer kids show surprising strength: study reveals growth, not just trauma

NCT ID NCT01044160

Knowledge-focused Sponsor: St. Jude Children's Research Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 25, 2026 · Updated 2 times

Summary

This study looks at how children with cancer and their parents handle the emotional challenges of the disease. Instead of focusing only on negative effects like posttraumatic stress, researchers also explore positive changes, such as personal growth. The study compares these families to those without a history of serious illness to better understand what helps people cope and thrive.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

663 people

The number who actually took part.

Started

Jul 2009

Expected to finish

Apr 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Recruitment from the oncology group will be from outpatient clinics with procedures designed to obtain a representative sample of research participants, in terms of diagnosis and time since diagnosis. Control group participants will be accessed through schools in the greater Memphis area.

Ages

3 to 25 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Primary Group * Research participant is 8-17 years inclusive * Research participant has a primary diagnosis of malignancy * Research participant is at least one month from diagnosis with no upper limit in terms of time elapsed since diagnosis; * Research participant is able to speak and read English; * Research participant does not have any significant cognitive or sensory deficits that would preclude participation; * Parent/LAR and research participant is willing to participate and provide consent/assent Young Child Group * Research participant is 3 - 6 years of age, inclusive * Primary diagnosis of malignancy * At least one month from diagnosis * One parent/LAR willing to participate and provide consent * No history of sensory or developmental disorder that would invalidate study assessment procedures. Young Adult Group * Research participant is 18-25 years of age inclusive * Primary diagnosis of malignancy * At least one month from diagnosis with no upper limit in terms of time elapsed from diagnosis * Able to read and speak English * No cognitive or sensory deficits that would preclude participation * Willing to participate and provide consent Control Groups * Research participant in 3 age groups (3 - 6 years; 8-17 years; 18-25 years) to match patient groups * No history of chronic or life-threatening illness * No cognitive or sensory impairment that would preclude completion of study measures * Able to speak and read English * Parent/LAR and research participant are willing to participate and provide informed consent/assent Exclusions Criteria:NA

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malignancy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Posttraumatic growth Posttraumatic stress disorder

Contacts and locations

Locations

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.